DoW Lupus, Impact Award

US · MD Dept › of the Army -- USAMRAA (U › S › Army Medical Research Acquisition Activity) grant open #HT942526LRPIPA

Response due Aug 24, 2026 · 00:00 UTC

Summary

This is a Department of Defense (DoD) / Department of the Army funding opportunity administered by the U.S. Army Medical Research Acquisition Activity (USAMRAA) under the Congressionally Directed Medical Research Programs (CDMRP). It targets lupus research under the Lupus Research Program (LRP), specifically an "Impact Award" mechanism. The opportunity is posted on Grants.gov and is open for proposals from May 2026 through August 2026. Full scope details are not provided in the synopsis; applicants should consult the full program announcement for eligibility, scope, and submission requirements.

What they want

The opportunity is a federal grant/cooperative agreement for lupus-related biomedical research under the DoD Lupus Research Program (LRP), Impact Award mechanism. The specific research scope, objectives, and deliverables are not detailed in the provided synopsis text. The award is numbered HT942526LRPIPA and is issued by USAMRAA (U.S. Army Medical Research Acquisition Activity) on behalf of the Department of the Army.

How they evaluate

Submission: Grants.gov federal grants portal

Risks & flags

Synopsis contains minimal detail — full scope, eligibility, and evaluation criteria are not disclosed in the posted text; applicants must locate the full program announcement separately.
No dollar value or award ceiling stated, making cost planning difficult.
Short title and description provide no substantive scope information, which limits competitive intelligence.

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541711

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Lupus, Impact Award

Due Aug 24

Onboard ↗